Rani Therapeutics Holdings Inc (RANI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	0.172	1.028	-
Operating Expenses	30.92% 7.257	10.51	12.19	15.99	11.80
Interest Income/Expense	17.33% 0.725	0.877	0.943	1.124	1.337
Benefits Costs and Expenses	29.49% 7.914	11.22	12.91	-	-
Costs And Expenses	29.49% 7.914	11.22	12.91	-	-
Depreciation and Amortization	7.08% 0.223	0.24	0.251	0.266	0.259
Operating Income/Loss	30.92% -7.257	-10.51	-12.01	-14.96	-11.80
Income/Loss From Continuing Operations Before Tax	29.49% -7.914	-11.22	-12.74	-15.72	-12.72
Income/Loss From Continuing Operations After Tax	29.49% -7.914	-11.22	-12.74	-15.72	-12.72
Net Income/Loss	29.49% -7.914	-11.22	-12.74	-15.72	-12.72
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	44.79% -2.502	-4.532	-5.474	-6.775	-5.939
Basic Average Shares	27.10% 46.44	36.54	33.44	-27.04	28.84
Diluted Average Shares	27.10% 46.44	36.54	33.44	-27.04	28.84
Basic Earnings Per Share	33.33% -0.12	-0.18	-0.22	-0.27	-0.24
Diluted Earnings Per Share	33.33% -0.12	-0.18	-0.22	-0.27	-0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-